A ‘fridge-free vaccine’ has the potential to transform African immunisation

“Fridge-free” vaccine for tetanus-diphtheria shows promise in first human trial

Half of vaccines are binned – ‘fridge-free’ versions could change that

Stablepharma & AFT to Expand Fridge-Free Vaccine Distribution Following Positive Clinical Data

Could ‘fridge-free’ vaccines transform global immunisation?

Stablepharma and AFT Pharmaceuticals partner to address multi-billion dollar anti-infective and oncology market

Stablepharma Announces Database Lock for Fridge-Free Tetanus-Diphtheria Vaccine Clinical Trial

Revolutionising global vaccine access: The case for Stablepharma’s fridge-free vaccine technology

Stablepharma enters Phase 1 Clinical Trials with world-first Fridge-Free Td Vaccine

BIA Spotlight: how Stablepharma is pioneering the world’s first fridge-free Td vaccine

Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus & Diphtheria (Td) Vaccine

Dr Kenny Simmen named Chief Business Officer of Stablepharma Ltd